Anish Bhatnagar - Jan 21, 2022 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role
Chief Executive Officer
Signature
/s/ Anish Bhatnagar
Stock symbol
SLNO
Transactions as of
Jan 21, 2022
Transactions value $
-$14,559
Form type
4
Date filed
1/25/2022, 04:50 PM
Next filing
Feb 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLNO Common Stock Sale -$14.6K -39K -9.54% $0.37 370K Jan 21, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted stock units.